HEALTHCARE ORGANIZATIONS HAVE PLACED INCREASING EMPHASIS on promoting patients' ability to advocate for their healthcare needs and priorities, and cancer care is no exception (Shapiro et al., 2009 ). Self-advocacy, generally defined as the ability to ensure that one's needs are met in the face of a challenge, is a foundational skill that can help an individual achieve improved health outcomes and quality of life (Walsh-Burke & Marcusen, 1999) . As patient advocates and experts in symptom management (Oncology Nursing Society, 2016) , oncology nurses must understand how the ability of patients to self-advocate relates to their ability to manage their cancer-and treatment-related symptoms. Although the concept of self-advocacy originated in populations with HIV and AIDS (Brashers, Haas, Neidig, & Rintamaki, 2002; Test, Fowler, Wood, Brewer, & Eddy, 2005) , the language of self-advocacy was broadly accepted by the oncology community, although without a unique conceptualization (Hermansen-Kobulnicky, 2008) . To provide conceptual clarity to what self-advocacy means for patients with cancer, the current authors conducted a content analysis and discovered that self-advocacy is a behavioral skill that equips individuals with the ability to actively engage in behaviors that support their autonomy and improve their quality of life (Hagan, Cohen, Stone, & Donovan, 2016) . In this study, the research team defined the unique ways in which women with cancer advocate for themselves when faced with a challenging situation (Hagan et al., 2016) . Self-advocacy for female cancer survivors consists of three primary ways in which they can have their needs met in the face of a challenge: making informed decisions, balancing personal needs with others' needs, and effectively communicating with members of the healthcare team (Hagan et al., 2016) .
Adult women with cancer experience high levels of symptom burden during and after treatment for cancer (Cheng, Wong, & Koh, 2016; Cheung, Le, Gagliese, & Zimmermann, 2011; Falk et al., 2016) . Cancer-related symptoms can persist years after treatment has ended and affect an individual's functional ability and quality of life (Huang et al., 2016; Ness et al., 2013) . A recent review article of cancer survivors by Wu and Harden (2015) revealed that one-third of cancer survivors continue to experience symptoms after their treatment has ended, with little reduction in severity. Symptom burden is a key area in which women with cancer can self-advocate, and 
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BACKGROUND: Although patient self-advocacy is a critical component of patient-centered care, the association between symptom burden and selfadvocacy has received little attention.
OBJECTIVES: This analysis evaluates the degree to which self-advocacy is associated with symptom burden among women with a history of cancer.
METHODS: Participants completed online or paper questionnaires. Descriptive statistics and ordinary least squares regression models were used to analyze the association between the three dimensions of self-advocacy and two dimensions of symptom burden: symptom severity and interference.
FINDINGS: Participants reported moderate levels of symptom burden. Fatigue, disturbed sleep, and memory problems were most common. Informed decision making was positively associated with symptom burden and participants' burden across the three most severe symptoms. Effective communication was negatively associated with total symptom burden and the degree to which symptoms interfered with daily life.
SYMPTOM BURDEN AND SELF-ADVOCACY
it is a key feature of oncology nursing care. If women can apply the skills of self-advocacy to their symptom burden needs, they may be able to proactively manage their symptoms by seeking evidence-based care from their healthcare team and selfmanaging their symptoms.
Based on the authors' previous research, Figure 1 illustrates the potential associations between predictors, moderators/ covariates, and outcomes of self-advocacy that were uncovered by the team's content analysis (Hagan et al., 2017) . This model proposes that high levels of the three dimensions of selfadvocacy on the Female Self-Advocacy in Cancer Survivorship (FSACS) Scale lead to improvements in symptom burden and healthcare use, although this relationship is moderated by patient demographics (e.g., age, education, income, insurance status) and health history (e.g., type of cancer, years since diagnosis, treatment status). To date, this model has not been tested, particularly the ways in which the three selfadvocacy dimensions relate to symptom burden.
The purpose of this exploratory study was to evaluate whether the different self-advocacy subscale scores were associated with symptom burden scores among female adult cancer survivors. The authors hypothesized that higher scores on the three self-advocacy subscales would be associated with lower symptom burden.
Methods

Sample
This is a secondary analysis of data from the current authors' self-advocacy study, a cross-sectional psychometric survey study of the FSACS Scale (Hagan et al., 2017) . Eligibility criteria for the parent study (N = 318) included female survivors of an invasive (i.e., not in situ or cervical intraepithelial neoplasia) cancer aged older than 18 years who could read and write in English. The authors did not limit the time since the woman's cancer diagnosis to capture the breadth of survivors' experiences. The authors recruited women from July 2014 to March 2015 using a mixture of random sampling from the Pennsylvania Cancer Registry, including women diagnosed with cancer from 1985-2013, and convenience sampling from a patient registry and seven local and national advocacy organizations. Various sources were used to ensure a diverse sample of women based on type of cancer, geographic area, racial and ethnic background, and socioeconomic status. Informed consent was obtained from all participants prior to survey administration. Each participant completed a web-or paper-based questionnaire packet (based on participant preference), including a battery of patientreported outcomes. For this analysis, the authors wanted to capture only the symptom burden of participants experiencing any symptoms; therefore, they excluded participants who reported having no symptoms (n = 139) (i.e., scoring 0 on all 13 symptom items), resulting in a final sample of N = 179. Participants received a $10 gift certificate after completing all surveys. The institutional review board at the University of Pittsburgh approved this study.
MODEL OF PATIENT SELF-ADVOCACY AMONG FEMALE CANCER SURVIVORS
Measures SELF-ADVOCACY (PREDICTOR):
The FSACS Scale is an assessment of how female cancer survivors advocate for their needs and priorities in the face of a challenge (Hagan et al., 2017) . Figure  2 lists the general item topics within each subscale. This multidimensional scale is comprised of three distinct complementary domains of patient self-advocacy: (a) gaining strength by giving support and receiving support from family and friends (connected strength), (b) communicating effectively with the healthcare team (effective communication), and (c) making informed decisions about health care based on relevant and trustworthy information (informed decision making). The conceptual model of self-advocacy proposes that if a woman with cancer develops skills in any of these dimensions, she will be more likely to ensure that her needs are met (e.g., the need of managing her cancer-and treatment-related symptoms) (Hagan et al., 2016) . The FSACS Scale is a 20-item Likert-type self-report survey; higher scores indicate greater ability to self-advocate. The scale's psychometric properties are strong, with the subscales' Cronbach alphas ranging from 0.79-0.85 and having strong evidence for validity (Hagan et al., 2017) . Given that the three subscales assess complementary yet distinct constructs, the authors used individual subscale total scores in all analyses.
SYMPTOM BURDEN (OUTCOME): The MD Anderson Symptom Inventory (MDASI) consists of two subscales measuring the severity of 13 common cancer-and treatment-related symptoms (symptom severity) and the extent to which those symptoms interfere with different activities in an individual's life (symptom interference). The severity subscale asks participants to rate the severity of each symptom they experience within the past 24 hours on an 11-point Likert-type scale ranging from 0 (not present) to 10 (as bad as you can imagine). The interference subscale asks participants to report how their symptoms interfered with six life activities during the past 24 hours on an 11-point Likert-type subscale ranging from 0 (did not interfere) to 10 (interfered completely). The MDASI is widely used and has excellent psychometric properties (Aktas, Walsh, & Kirkova, 2015) in heterogeneous cancer populations, as well as strong reliability (Cronbach alphas = 0.91-0.94) and validity properties (Cleeland et al., 2000) .
Considering the heterogeneity of symptoms women experienced, the authors evaluated the symptom severity subscale in two ways. First, they computed participants' mean scores across all 13 symptoms included on the MDASI. Second, they selected and calculated the mean symptom severity scores for the top three most severe symptoms reported by participants. For the symptom interference subscale, they calculated participants' mean interference scores across the six interference items. Note. Because of rounding, percentages may not total 100.
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SOCIODEMOGRAPHIC AND HEALTH HISTORY: The authors measured participants' sociodemographic characteristics using the revised sociodemographic form from the Center for Research in Chronic Disease at the University of Pittsburgh (Sereika & Engberg, 2006) . Health characteristics, including cancer stage at diagnosis and years since diagnosis, were gathered using an investigator-developed health questionnaire.
Statistical Analysis
After ensuring that all data met test assumptions, the authors conducted the analyses. To address their primary aim, they performed a stepwise multiple regression analysis to test the association between the self-advocacy subscales and the two symptom burden subscales. Separate models were conducted for the symptom severity (both for mean severity across all symptoms and mean severity for participants' top three symptoms) and symptom interference outcomes. Regression models were adjusted for age, highest educational level, years since diagnosis, and cancer stage at diagnosis because these variables were shown to correlate with self-advocacy in previous research (Hagan et al., 2017) , as well as with symptom burden (Cataldo et al., 2013; Mao et al., 2007) . All analyses were conducted using IBM SPSS Statistics, version 23.0.
Results
Descriptive statistics for the sample are reported in Table 1 . Participants (N = 179) had a mean age of 59 years (SD = 13.5, observed range = 21-88 years). Most participants were married, self-identified as White, and had private healthcare insurance. Although more than half of participants had a breast (n = 74) or ovarian (n = 35) cancer diagnosis, women (n = 70) reported more than 20 different cancer diagnoses, such as thyroid, endometrial, lymphoma, colorectal, cervical, melanoma, uterine, bladder, kidney, liver, vaginal, brain, leukemia, stomach, pancreatic, spleen, and 13 other cancers. Most participants (n = 76) had been initially diagnosed with cancer five or more years before the time of the current study. Forty had been diagnosed less than one year, and 61 had been diagnosed one to five years, before the start of the study (missing, n = 2). These estimates are similar to the larger population of female cancer survivors in western Pennsylvania and the United States (Siegel, Miller, & Jemal, 2017) . Participants reported a variety of educational and income levels.
Descriptive statistics for self-advocacy and symptom burden are reported in Table 2 . The self-advocacy scale's three dimensions demonstrated sufficient variability in scores. These subscales had low to moderate intercorrelations, with Pearson correlations ranging from 0.29-0.49. Across all symptoms, the five most severe symptoms reported by women in order of decreasing severity were fatigue ( 
Symptom Burden and Self-Advocacy
The three FSACS subscales of self-advocacy demonstrated low correlations with the two MDASI subscales of symptom burden (see Table 3 ). Informed decision making and connected strength did not demonstrate any significant associations. Effective communication was negatively associated with symptom severity "Women who had a higher ability to communicate with their healthcare providers reported less severe symptoms." across all but the top three symptoms (r = -0.18, p < 0.02) and symptom interference (r = -0.33, p < 0.001). Table 4 reports the stepwise multiple regression results describing the association between symptom burden and self-advocacy. SYMPTOM SEVERITY: For the model considering all 13 symptoms, the self-advocacy subscales and covariates significantly explained 11% of the variance in symptom severity scores (R 2 = 0.11, F[6, 167] = 3.44, p = 0.003). In this model, the informed decision making (β = 0.19, p = 0.04) and effective communication (β = -0.25, p = 0.006) subscales demonstrated significant associations with symptom severity. The higher a woman's ability to gather and apply health information to her illness, the more severe her symptoms were. Women who had a higher ability to communicate with their healthcare providers reported less severe symptoms. The model considering only the top three symptoms explained 8% of the variance in symptom severity scores (R 2 = 0.08, F[6, 167] = 3.44, p = 0.003). In this model, the informed decisionmaking subscale demonstrated a significant association with symptom severity (β = 0.18, p = 0.04). Lower levels of education were associated with higher symptom severity in both models.
SYMPTOM INTERFERENCE: For the MDASI symptom interference subscale, the regression model explained 20% of the variance in how symptoms interfered with women's lives (R 2 = 0.2, F[6, 168] = 3.77, p = 0.002). Effective communication was the only self-advocacy subscale significantly associated with symptom interference (β = -0.33, p = 0.005). Specifically, the more a woman was able to communicate her needs and priorities to her healthcare provider, the less her symptoms interfered with her life. None of the moderators (age, years since diagnosis, cancer stage at diagnosis, highest educational level) were independently associated with symptom interference.
Discussion
Women reported moderate rates of symptom severity and interference. The most prevalent symptoms included fatigue, disturbed sleep, memory problems, and depression, which is consistent with other studies describing the most common symptoms reported by cancer survivors (Huang et al., 2016) . The regression analyses demonstrated that specific subscales of self-advocacy significantly related to each symptom burden subscale. In particular, a woman's ability to make informed decisions about her health was associated with higher symptom severity, and her ability to communicate effectively with her healthcare team was associated with lower symptom severity and interference. The FSACS connected strength subscale did not independently associate with either symptom burden subscale.
The positive association between informed decision making and symptom severity contradicted the authors' hypothesis and suggests that women who are comfortable gathering and applying health information to their cancer experience may also be acutely aware of their cancer-and treatment-related symptoms. Alternatively, these findings may reflect that women who experience many symptoms may be more likely to gather and apply health information. However, higher levels of education were associated with lower symptom severity. As a result, although a woman's level of education may broadly indicate her socioeconomic status and access to healthcare resources, her ability to engage in informed decision making may specifically relate to how she addresses concerns regarding her body (e.g., symptoms, side effects, reactions to cancer and treatment).
The negative association between effective communication and symptom severity existed only when collectively analyzing all 13 symptoms and not for a woman's three most severe symptoms. Moreover, effective communication was negatively associated with symptom interference. These findings suggest that a woman who can openly and thoughtfully discuss her concerns with her healthcare providers may receive relevant, useful information that may help her address her symptoms. The results highlight the need for cancer survivors to engage in high-quality communication regarding symptom management with their healthcare team (Donovan, Hartenbach, & Method, 2005; Street, Makoul, Arora, & Epstein, 2009) , particularly because the most severe symptoms are also notoriously difficult to treat (e.g., fatigue, drowsiness, memory problems).
Although being a self-advocate may raise patients' awareness of symptoms, it may also equip patients with skills like communication that enable them to address those concerns. Dong et al. (2016) found similar connections between self-advocacy and the experience of multiple symptoms among patients with cancer. In their qualitative study, patients described how cancer-and treatment-related symptoms interfered with their ability to remain autonomous and independent, requiring patients to self-advocate. This helps clarify the positive relationship found in this study between symptom severity and informed decision making, and suggests that the relationship between self-advocacy and symptoms may be bidirectional, implying that self-advocacy skills develop in response to high symptom burden. Clinical oncology nurses can use these findings while caring for patients with cancer. Nurses can assess if their patients are able to actively engage in decision making about their health care and assess their level of comfort discussing their concerns with their healthcare providers. Nurses should pay special attention to patients' symptom management needs if they struggle in this respect. Even if patients engage in decision making and are educated, they may not be able to effectively manage their symptoms. Oncology nurses can support their patients in learning how to engage in open communication, providing them with skills they can use in addressing their symptoms. Although it was surprising that decision making was related to higher symptom burden, nurses can help their patients apply their decision-making skills to directly address their symptom management needs and ensure they are effective at improving their symptoms.
Limitations
Limitations to this analysis include the cross-sectional nature of the study, which involved the self-reported symptom burden measure. Symptom burden was assessed in the past 24 hours, and whether the symptoms participants reported were directly related to their cancer or another illness is unknown. Because the authors were interested in the association between selfadvocacy and symptom burden, the etiology of the symptoms may not matter as much as the women's ability to actively manage those symptoms. The authors did not assess participants' comorbidities. Last, the sample included women who were recently diagnosed with cancer and who were long-term survivors, as well as patients diagnosed with any type of invasive cancer. The sample did not include patients with diverse cultural, social, and religious backgrounds, which likely influence women's experiences of self-advocacy (e.g., poverty, under-or uninsured populations, cultural norms that place less emphasis on individualism). Although such heterogeneity may reduce the specificity of the results, it does provide an inclusive review of symptom burden, which has yet to be investigated among women with cancer.
Conclusion
This study demonstrates that two of the three dimensions of self-advocacy (informed decision making and effective communication) are associated with symptom severity and interference among female adult cancer survivors. Prospective studies are needed to reveal the temporal relationship between selfadvocacy and symptom burden during other stages of the cancer experience.
